Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2025-12-24 @ 5:55 PM
NCT ID:
NCT05013268
Brief Title:
Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma
Official Title:
The Efficacy and Safety of Tislelizumab Combined With Taxanes and Platinum as Neoadjuvant Therapy for Patients With Local Advanced Cervical Carcinomaļ¼ an Open Lableļ¼Single-center, Exploratory Clinical Trial
Acronym:
TiTanec
Study:
NCT05013268
Protocol Section:
NCT05013268